*Please note that Expert Review of Precision Medicine and Drug Development converted to a full Open Access journal from Volume 8 (2023). Previous volumes will continue to provide access through a Pay to Read model.
Expert Review of Precision Medicine and Drug Development [e-ISSN 2380-8993] is an international open access journal publishing rigorously peer-reviewed review articles and original papers on the development and clinical application of medicine to be used in a personalised therapy setting.
In an era where medicine is recognizing that a one-size-fits-all approach is not always appropriate, Expert Review of Precision Medicine and Drug Development supports the necessity to identify patients responsive to treatments and treat patient populations using a tailored approach.
Articles focus on the following key areas:
- Development and application of drugs targeted to specific genotypes and populations, as well as advanced diagnostic technologies and significant biomarkers that aid in this;
- Clinical trials within personalised therapy and drug development;
- Screening, prediction and prevention of disease, prediction of adverse events, treatment monitoring, effects of metabolomics and microbiomics on treatment;
- Secondary population research, genome-wide association studies, disease–gene association studies, personal genome technologies;
- Ethical and cost–benefit issues, the impact to healthcare and business infrastructure, and regulatory issues.
Please note that the journal does not publish case reports, case series or animal studies
Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections:
Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results;
Article Highlights – an executive summary of the author’s most critical points.
Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.
Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Review of Precision Medicine and Drug Development, part of the Expert Collection brand.
For any pre-submission enquiries, please contact the Commissioning Editor.
Editor-in-Chief:
Professor Liang Cheng (MD),Vice Chair for Translational Research, Brown University, Providence, RI, USA.
Research Interests: Pathology; Urology; Genitourinary Cancers; Molecular Diagnostics
Editorial Board Members:
Professor Juan-Manuel Anaya (MD, PhD), Universidad del Rosario, Bogotá, Colombia.
Research Interests: Genetics; Autoimmune Diseases; Translational Medicine; Immunogenetics
Professor Simone Appenzeller (MD, PhD), University of Campinas, Campinas, Brazil.
Research interests: lupus erythematosus, autoimmune disease, autoinflammatory disease, CNS involvement
Dr William CS Cho (PhD), Queen Elizabeth Hospital, Yau Ma Tei, Hong Kong.
Research Interests: Molecular Oncology; MicroRNA; Lymphoma; Tumor Marker Discovery; Bioinformatics
Dr Alessia Cimadamore (MD, PhD), Polytechnic University of the Marche Region, Ancona, Italy.
Research Interests: Molecular Biomarkers; Prostate Cancer; Renal Cell Carcinoma; Bladder Cancer
Dr Dimitar Dimitrov (PhD), University of Pittsburgh, Pittsburgh, PA, USA.
Research Interests: Novel Human Monoclonal Antibodies; Therapeutics Antibodies in Clinical Trials
Professor Henk-Jan Guchelaar (PharmD, PhD), Leiden University Medical Center, Leiden, The Netherlands.
Research Interests: Pharmacogenetics; Pharmacogenetic Biomarkers; Personalised Therapeutics
Professor Michael A Jacobs (PhD), Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
Research Interests: Brain Cancer; Brain Metastases; Breast Imaging; Locally Advanced Breast Cancer; Radiomics
Professor Adrian Llerena (PhD), Extremadura University Hospital and Medical School, Badajoz, Spain.
Research Interests: Pharmacogenetics; Pharmacogenomics; Genotyping; Psychopharmacology
Dr Antonio Lopez-Beltran (MD), Cordoba University Medical School, Cordoba, Spain.
Research Interests: Urologic Cancer, Uropathology, Bladder Cancer, Prostate Cancer
Professor Anil K Malhotra (MD), The Zucker Hillside Hospital, Glen Oaks, NY, USA.
Research Interests: Neuroscience; Psychiatry; Schizophrenia; Anti-psychotic Drugs; Molecular Genetics
Dr Nafees Malik (MD), Juvenescence, Ormskirk, UK.
Research Interests: Gene therapy; T-cell Therapies in Oncology; Biotech
Professor Arduino A Mangoni (MD, PhD), Flinders University and Flinders Medical Centre, South Australia, Australia.
Research Interests: Clinical Pharmacology; Cardiology; Drug Safety; Drug Discovery; Biomarkers
Dr Francesco Massari (MD), Oncologia Medica, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Research Interests: Genitourinary Cancer
Professor Mark McCarthy (MD), University of Oxford, Oxford, UK.
Research Interests: Diabetes; Gene Identification in Type 2 Diabetes; Personalised Medicine; Sequencing; Genetic Epidemiology
Professor Rodolfo Montironi (MD), Polytechnic University of the Marche Region, Ancona, Italy.
Research Interests: Genitourinary Tumor Pathology; Urology; Prostate Cancer; Urologic Oncology
Professor Edouard Nice (PhD), Monash University, Victoria, Australia.
Research Interests: Biomarker Discovery and Validation; Colorectal Cancer; Biosensor Analysis; Proteomics
Professor Shuji Ogino (MD, PhD), Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Research Interests: Molecular Diagnostics; Precision Public Health; Colorectal Cancer; Transdisciplinary Epidemiology
Professor Godefridus J Peters (PhD), VU University Medical Center, Amsterdam, The Netherlands.
Research Interests: Cancer; Anti-Cancer Drugs; Cancer Biomarkers; Biotechnology
Professor Sir Munir Pirmohamed (PhD), University of Liverpool, Liverpool, UK.
Research Interests: Pharmacogenetics; Pharmacogenomics; Drug Safety; Precision Medicine; HLA
Professor Etheresia Pretorius (PhD), Stellenbosch University, Stellenbosch, South Africa.
Research Interests: Inflammatory Markers; Nanobiosensors; Platelets; Scanning Electron Microscopy
Professor Shahrokh Shariat (MD), Medical University of Vienna, Vienna, Austria.
Research Interests: Urologic Oncology; Markers; Early Detection; Translational Research; Outcomes Research
Professor Catherine Sherwin (PhD), Wright State University, Dayton Children's Hospital, Dayton, OH,USA.
Research Interests: Paediatrics; Toxicology; Antibiotics, Immunosuppressants, Antiepileptics; Pharmacometrics
Dr Jean-Claude Tardif (MD), Montreal Heart Institute, Montreal, Canada.
Research Interests: Cardiovascular Disease; Atherosclerosis; Personalised Medicine; Biomarkers
Professor Brian Tomlinson (MD), The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong.
Research Interests: Lipid Disorders; Hypertension; Personalised Medicine
Dr Tian Zhang (MD), Duke Cancer Institute, Durham, NC, USA.
Research Interests: Medical Oncology; Genitourinary Cancers
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110817/Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
![HRB Open Research is a platform for HRB-funded researchers to rapidly publish their research outputs in an open and accessible way.]({"type":"image" , "src" : "/sda/112432/HRB-KB.jpg"})